Y-Biologics (XKRX:338840) Ending Cash Position : ₩16,997 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Ending Cash Position?

Y-Biologics's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩16,997 Mil.

Y-Biologics's quarterly Ending Cash Position increased from Sep. 2023 (₩9,952 Mil) to Dec. 2023 (₩20,535 Mil) but then declined from Dec. 2023 (₩20,535 Mil) to Mar. 2024 (₩16,997 Mil).

Y-Biologics's annual Ending Cash Position declined from Dec. 2020 (₩33,389 Mil) to Dec. 2021 (₩16,873 Mil) and declined from Dec. 2021 (₩16,873 Mil) to Dec. 2022 (₩12,614 Mil).

Y-Biologics Ending Cash Position Historical Data

The historical data trend for Y-Biologics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Ending Cash Position Chart

Y-Biologics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

Get a 7-Day Free Trial

33,875.68

25,516.88

33,389.08

16,872.73

12,613.66

Y-Biologics Quarterly Data
	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial				11,343.58	10,930.59	9,952.13	20,535.47	16,996.55

Y-Biologics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Y-Biologics's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	16872.731	+	-4259.069
	=	12,614

Y-Biologics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	20535.468	+	-3538.922
	=	16,997

Y-Biologics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics (XKRX:338840) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR

Website

https://www.ybiologics.com

Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines